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The article of Crisafulli et al. entitled 'The heart rate recovery is associated with ventilatory constraints and excess ventilation during exercise in patients with chronic obstructive pulmonary disease' 1 sheds light on the relationship of heart rate recovery (HRR) with dynamic hyperinflation and ventilatory efficiency during cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease (COPD). Specifically, patients with HRR delay were found to be characterised by both decreased ratio of inspiratory capacity to total lung capacity (IC/TLC) at peak and increased minute ventilation to carbon dioxide output (VE/VCO 2 ) slope. An inverse association between HRR and VE/VCO 2 slope has been previously reported only in patients with heart failure (HF). 2 The issue of whether this relationship exists in the general healthy population remains to be investigated. Moreover, the relationship between HRR and dynamic hyperinflation has not been investigated before.
Importantly, Crisafulli et al. have demonstrated that the associations of HRR with dynamic hyperinflation and excess ventilation were independent from the effects of all the usual confounders encountered in cardiopulmonary exercise testing, indicating the possible existence of a direct pathophysiological link between the associated parameters. Specifically, dynamic hyperinflation results in decreased tidal volume during exercise, leading inevitably to increased respiratory rate to meet the demands of excess ventilation. Taking into account that higher respiratory rate above a characteristic frequency causes sympathetic activation and vagal withdrawal, both dynamic hyperinflation and excess ventilation can induce a delayed HRR. 3 The great usefulness of delayed HRR, a marker of parasympathetic dysfunction, in patients with COPD is suggested by the fact that COPD is accompanied with autonomic dysfunction, characterised by both impaired parasympathetic and impaired sympathetic function. 4 Both delayed HRR and chronotropic incompetence, a marker of sympathetic dysfunction, are very common in COPD patients and appear to be more frequent with increasing Global Initiative for Chronic Obstructive Lung Disease (GOLD) severity of COPD. 3 Consistently, Crisafulli and coworkers found that forced expiratory volume at first second (FEV1) was decreased in COPD patients with delayed HRR compared to those with normal HRR. The high value of HRR in clinical practice lies firstly in its simplicity and low cost among other measures of cardiac autonomic function, and secondly in its well-established cardiovascular prognostic significance, as evidenced by its ability to predict cardiovascular mortality mainly in patients with cardiovascular disease, as well as in primary prevention. 5, 6 The underlying mechanisms that are responsible for the association between delayed HRR and cardiovascular mortality include firstly the relationship between HRR and cardiorespiratory fitness, since the latter can predict cardiovascular mortality, and secondly the fact that delayed HRR reflects attenuated parasympathetic tone and hence greater risk for malignant cardiac arrhythmias and sudden cardiac death, given the antiarrhythmic effect of increased parasympathetic tone. 7 Although HRR has been reported to predict non-cardiovascular mortality, its prognostic performance appears to be better for the prediction of cardiovascular death. 6 Laboratory of Sports Medicine, Aristotle University of Thessaloniki, Greece
An important limitation in the wide-spread application of HRR in clinical practice as a prognostic tool is the lack of any standardization for HRR assessment. In this respect, there are no universally accepted exercise and recovery protocols for HRR measurement. With regard to the exercise protocol, the Bruce (standard or modified) protocol is the most commonly used and the most well-studied for this purpose. HRR evaluation is better to be performed during the first 60 s of active recovery (cool-down), since the major studies evaluating the prognostic performance of HRR have applied this methodology. The rationale of the assessment of HRR only in the first minute of recovery lies in the fact that this period represents the first fast phase of recovery that is solely attributed to parasympathetic reactivation and not influenced by the intensity of the preceding exercise. 8 On the contrary, the second slow phase is attributed to sympathetic withdrawal, is clearly dependent on exercise intensity and is less predictable, since the underlying mechanisms that are activated are the muscle metaboreflex and thermoregulation. 7 Considering that the first fast phase of HRR is not influenced by exercise intensity and achieved workload, HRR during the first one minute of recovery can be assessed simply by recording the first one minute of cool-down after a submaximal exercise test. Association between HRR and CRF Figure 1 . The influence of dynamic hyperinflation and excess ventilation during exercise on heart rate recovery (HRR)-based prognosis. A portion of the cardiovascular prognostic significance of HRR in chronic obstructive pulmonary disease (COPD) may be attributed to the modulation of HRR by dynamic hyperinflation (DH) and excess ventilation (EV). The cardiovascular prognostic potential of these two factors is mediated through the downregulation of the parasympathetic nervous system predisposing the COPD patient to malignant ventricular arrhythmias. Conversely, the HRR-based prognosis in COPD may comprise a non-cardiovascular element, reflecting the induction of non-cardiovascular COPD-related events by DH and EV. CRF: cardiorespiratory fitness.
prognostic tool (Figure 1 ). Taking into account, firstly the fact that cardiovascular disease is a more prevalent cause of mortality than respiratory failure in patients with mild to moderate COPD, and secondly that COPD per se is a risk factor for cardiovascular disease independently of smoking history, the evaluation of cardiac autonomic function through HRR can be particularly useful in the cardiovascular prognostic stratification of COPD patients. 9, 10 Additionally, increased VE/VCO2 slope has been found to be an adverse prognostic marker predicting mortality in patients with HF, as well as in COPD patients undergoing lung resection. 2, 11 Notably, HRR and VE/VCO2 slope can independently predict future cardiac events in HF patients. 1 Although static lung hyperinflation has been linked with increased all-cause and respiratory mortality in patients with COPD, the prognostic significance of dynamic hyperinflation remains to be elucidated. 12 Despite the fact that the prognostic significance of dynamic hyperinflation and excess ventilation during exercise has not been properly investigated in COPD, these parameters may have an adverse cardiovascular impact through the induction of autonomic dysfunction in patients with COPD. In this respect, a portion of the cardiovascular prognostic significance of HRR in COPD may be attributed to the modulation of HRR by dynamic hyperinflation and excess ventilation (Figure 1) . Conversely, the HRR-based prognosis in COPD may comprise a non-cardiovascular element, reflecting the induction of non-cardiovascular COPDrelated events by dynamic hyperinflation and excess ventilation (Figure 1) . Indeed, the HRR-based prognosis has been found to involve prediction of all-cause mortality in patients with COPD, incorporating prediction of not only cardiovascular death, but also noncardiovascular COPD-related death, including those deaths due to end-stage COPD and lung cancer. 13 Therefore, HRR appears to be a valuable prognostic tool in patients with COPD, that is simple, inexpensive and without the need to perform cardiopulmonary exercise testing. It should be acknowledged that cardiopulmonary exercise testing provides many parameters with well-established prognostic significance and if it is available is prudent to be performed in COPD patients and not substituted by HRR on a routine basis. Further studies are needed to establish a standardised protocol of HRR assessment for clinical use and to evaluate the prognostic performance of HRR in COPD.
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